AstraZeneca's diabetes drug granted fast track designation for heart failure; Verrica sends skin infection treatment to FDA
→ A couple weeks after announcing that their diabetes drug cut the risk of CV death or worsening of heart failure by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
